Taylor Morrison Home
TMHC
Meritage Homes
MTH
D.R. Horton
DHI
Lennar Corp
LEN
Toll Brothers
TOL
US Stock MarketDetailed Quotes
DNA Ginkgo Bioworks
- 10.290
- -0.170-1.63%
Close Feb 25 16:00 ET
- 8.750
- -1.540-14.97%
Pre 08:52 ET
597.17MMarket Cap-0.98P/E (TTM)
10.560High9.425Low2.88MVolume10.400Open10.460Pre Close28.73MTurnover7.24%Turnover RatioLossP/E (Static)58.03MShares52.80052wk High0.83P/B409.34MFloat Cap5.26052wk Low--Dividend TTM39.78MShs Float634.560Historical High--Div YieldTTM10.85%Amplitude5.260Historical Low9.980Avg Price1Lot Size
Ginkgo Bioworks Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.15%-319.59M | 26.62%-42.44M | -40.72%-103.5M | -14.76%-84.39M | 1.46%-89.26M | -17.17%-295.5M | 44.68%-57.83M | -159.34%-73.55M | 26.03%-73.53M | -355.25%-90.59M |
| Net income from continuing operations | 38.73%-547.03M | 49.20%-107.53M | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M |
| Operating gains losses | -67.60%30.98M | -72.06%13.39M | -64.00%12.4M | -46.13%3.59M | -75.75%1.6M | 268.76%95.64M | 313.65%47.92M | 64.55%34.43M | -73.67%6.67M | 108.22%6.62M |
| Depreciation and amortization | -11.93%63.02M | 12.73%15.65M | -18.48%17.17M | -1.82%17.33M | -32.12%12.87M | 61.07%71.55M | -20.83%13.88M | 166.14%21.06M | 75.96%17.65M | 112.06%18.96M |
| Deferred tax | -16.85%-936K | ---- | ---- | ---- | ---- | 94.52%-801K | ---- | ---- | ---- | ---- |
| Other non cash items | 6.77%53.23M | 6.16%8.46M | -29.67%7.52M | -4.11%16.16M | 47.07%21.09M | 495.56%49.85M | 165.50%7.97M | 30.45%10.7M | 220.70%16.85M | 169.29%14.34M |
| Change In working capital | -400.53%-89.67M | -94.82%2.18M | -5,272.11%-98.04M | 149.49%5.88M | -79.03%312K | 180.63%29.84M | 628.41%42.06M | -104.39%-1.83M | 79.06%-11.88M | 110.71%1.49M |
| -Change in receivables | -109.44%-4.73M | -95.24%1.38M | -186.62%-5M | -64.40%5.67M | -1,187.07%-6.77M | -9.01%50.07M | -16.24%28.9M | -90.24%5.77M | 533.87%15.92M | 98.49%-526K |
| -Change in prepaid assets | -3.70%10.09M | 313.94%6.6M | 16.80%1.72M | -86.74%616K | -84.49%1.15M | 222.88%10.47M | 77.58%-3.08M | 71.53%1.47M | 9.37%4.65M | 5,806.35%7.44M |
| -Change in payables and accrued expense | -326.95%-35.67M | -122.24%-4.57M | -5,029.95%-41.96M | 99.97%-7K | -43.02%10.87M | 131.13%15.72M | 153.16%20.54M | 91.50%-818K | 39.97%-23.08M | -47.33%19.08M |
| -Change in other current assets | 86.31%22.07M | -42.63%3.04M | 12.60%5.49M | 1,268.59%14.25M | -212.40%-707K | -16.31%11.85M | -62.16%5.3M | 765.72%4.87M | 139.57%1.04M | -71.56%629K |
| -Change in other current liabilities | 42.78%-12.79M | -11.03%-3.4M | -47.05%-7.52M | 91.32%-544K | 83.25%-1.32M | -107.68%-22.35M | -0.92%-3.06M | -420.30%-5.11M | -143.79%-6.27M | 66.56%-7.9M |
| -Change in other working capital | -91.12%-68.65M | 86.75%-866K | -533.80%-50.77M | -240.66%-14.1M | 83.10%-2.91M | 1.37%-35.92M | -521.20%-6.54M | 48.84%-8.01M | 86.71%-4.14M | -250.59%-17.23M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.15%-319.59M | 26.62%-42.44M | -40.72%-103.5M | -14.76%-84.39M | 1.46%-89.26M | -17.17%-295.5M | 44.68%-57.83M | -159.34%-73.55M | 26.03%-73.53M | -355.25%-90.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 22.87%-62.24M | 71.97%-13.09M | -201.69%-10.2M | -139.14%-26.84M | 37.62%-12.11M | -19.73%-80.69M | -256.94%-46.67M | 92.73%-3.38M | 23.45%-11.22M | 46.05%-19.41M |
| Net PPE purchase and sale | -70.16%-61.89M | -576.56%-13.65M | -241.05%-14.69M | -153.05%-26.84M | 65.49%-6.71M | 30.41%-36.37M | 92.16%-2.02M | 67.95%-4.31M | -11.02%-10.61M | -451.99%-19.44M |
| Net business purchase and sale | 87.44%-5.4M | --0 | --0 | --0 | ---5.4M | -261.30%-42.98M | -152.18%-42.98M | --0 | --0 | --0 |
| Net investment purchase and sale | --4.52M | --568K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | 140.15%538K | --0 | ---- | ---- | ---- | 96.48%-1.34M | 95.45%-1.68M | -82.67%926K | ---617K | --27K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 22.87%-62.24M | 71.97%-13.09M | -201.69%-10.2M | -139.14%-26.84M | 37.62%-12.11M | -19.73%-80.69M | -256.94%-46.67M | 92.73%-3.38M | 23.45%-11.22M | 46.05%-19.41M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 45.93%-1.74M | 67.88%-203K | -47.62%-465K | 83.64%-226K | 4.84%-845K | -103.37%-3.22M | -100.65%-632K | 19.44%-315K | -63.82%-1.38M | 25.50%-888K |
| Net issuance payments of debt | 30.73%-897K | 36.16%-203K | 39.21%-200K | 38.65%-200K | 8.70%-294K | -4.69%-1.3M | 2.15%-318K | -8.58%-329K | -0.93%-326K | -12.59%-322K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -9.68%84K | --0 | --0 | 16.67%14K | 483.33%70K | -61.25%93K | --14K | --55K | --12K | -84.00%12K |
| Net other financing activities | 54.02%-926K | --0 | -546.34%-265K | 96.25%-40K | -7.44%-621K | 32.17%-2.01M | 77.46%-328K | 53.41%-41K | -139.78%-1.07M | 41.08%-578K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 45.93%-1.74M | 67.88%-203K | -47.62%-465K | 83.64%-226K | 4.84%-845K | -103.37%-3.22M | -100.65%-632K | 19.44%-315K | -63.82%-1.38M | 25.50%-888K |
| Net cash flow | ||||||||||
| Beginning cash position | -27.75%989.58M | -39.56%661.54M | -33.81%775.74M | -29.51%887.21M | -27.75%989.58M | -14.02%1.37B | -18.65%1.09B | -17.51%1.17B | -18.05%1.26B | -14.02%1.37B |
| Current changes in cash | -1.09%-383.56M | 47.00%-55.72M | -47.79%-114.17M | -29.39%-111.46M | 7.82%-102.21M | -69.19%-379.41M | -557.67%-105.14M | -2.67%-77.25M | 25.04%-86.14M | -94.28%-110.89M |
| Effect of exchange rate changes | 52.21%-281K | -171.57%-73K | 82.05%-35K | 96.59%-16K | -503.85%-157K | -164.76%-588K | -90.72%102K | -124.14%-195K | -388.54%-469K | -225.00%-26K |
| End cash Position | -38.79%605.74M | -38.79%605.74M | -39.56%661.54M | -33.81%775.74M | -29.51%887.21M | -27.75%989.58M | -27.75%989.58M | -18.65%1.09B | -17.51%1.17B | -18.05%1.26B |
| Free cash flow | -13.63%-382.13M | 8.38%-56.15M | -52.17%-118.59M | -27.97%-111.42M | 12.78%-95.97M | -10.45%-336.3M | 52.93%-61.28M | -86.29%-77.93M | 20.11%-87.07M | -368.63%-110.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.